Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bayreuth
Clinical trial register · Germany

Clinical Trials in Bayreuth, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hoffmann-La Roche2 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 Takeda2 NovaGo Therapeutics AG2 Bristol-Myers Squibb1
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Bayreuth

34 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
NG004 in Incomplete Spinal Cord Injury Patients
NCT07840196Acute Spinal Cord Injury (SCI), Spinal Cord Diseases, Spinal Cord Injuries, Trauma Nervous System
DrugNG004
NovaGo Therapeutics AG
Phase 1
120
Bayreuth, Bochum, Halle, Hamburg, Heidelberg, Murnau am Staffelsee, Tübingen
2026-08-05
Recruiting
Takeda
Phase 3
300
Bayreuth, Münster, Halle, Berlin
2026-05-21
Recruiting
Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons
NCT07788729Cancer, Lung Cancer, Colorectal Cancer, Hematological Cancer
University of Regensburg
Not applicable
384
Augsburg, Erlangen, Regensburg, Würzburg, Bayreuth, Berlin, Cologne
2026-04-21
Recruiting
University Hospital, Grenoble
Observational
1,600
Bayreuth, Göttingen, Jena, Mannheim, Ulm
2026-01-15
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Aachen, Bad Homburg, Bayreuth, Bochum, Bremen, Erbach/Odenwald, Freiburg im Breisgau, Hamburg
2025-09-17
Active, closed
NG004 in Spinal Cord Injury Patients
NCT06817577Acute Spinal Cord Injury (SCI), Spinal Cord Diseases, Central Nervous System Diseases, Nervous System Diseases
DrugNG004
NovaGo Therapeutics AG
Phase 1
20
Bayreuth, Halle, Heidelberg, Murnau am Staffelsee
2024-12-18
Recruiting
Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
NCT06201234Hormone Receptor Positive HER-2 Negative Breast Cancer, Advanced or Metastatic Breast Cancer, BRCA1 Mutation, BRCA2 Mutation
DrugsElacestrant·Olaparib
GBG Forschungs GmbH
Phase 2
176
Stuttgart, Tübingen, Winnenden, Weinheim, Augsburg, Bayreuth, Fürstenwalde, Frankfurt am Main
2024-12-13
Active, closed
Celgene
Phase 3
850
Ulm, Augsburg, Bayreuth, Erlangen, Langen, Hanover, Koblenz, Halle
2024-06-19
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Bayreuth, Böblingen, Erbach im Odenwald, Ulm
2024-05-24
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Bayreuth, Berlin, Bochum, Dresden, Düsseldorf, Essen, Giessen, Hamburg
2024-04-16
Recruiting
University of Bayreuth
Not applicable
220
Bamberg, Bayreuth, Coburg, Donaustauf, Kulmbach, Regensburg, Straubing
2024-02-15
Recruiting
PROCARE - PROstate Cancer Real World Evidence Registry
NCT06835218Prostate Cancer, Biochemical Recurrence of Malignant Neoplasm of Prostate, Non-metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
UroTrials Company (GmbH)
Observational
5,000
Freiburg im Breisgau, Heidelberg, Mannheim, Nürtingen, Tübingen, Ulm, Augsburg, Bayreuth
2024-01-29
Active, closed
Ad scientiam
Not applicable
336
Bayreuth, Dresden, Erbach im Odenwald
2023-09-22
Recruiting
Goethe University
Phase 2
220
Aachen, Aschaffenburg, Augsburg, Bad Saarow, Bayreuth, Berlin, Bielefeld, Bochum
2023-07-14
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Böblingen, Bayreuth, Erbach im Odenwald, Homburg, Frankfurt am Main
2023-07-11
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Ulm, Augsburg, Bayreuth, Erlangen, Munich, Cottbus, Hamburg, Chemnitz
2023-06-22
Active, closed
Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease
NCT06962891Chronic Kidney Disease(CKD), Progression, Disease
Angel Argiles
Observational
213
Bayreuth
2023-05-02
Recruiting
AstraZeneca
Phase 3
4,300
Aachen, Augsburg, Bayreuth, Berlin, Bonn, Deggendorf, Dessau, Dresden
2023-03-31
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Augsburg, Bayreuth, Berlin, Bottrop, Braunschweig, Bremen, Chemnitz, Dessau
2022-12-16
Active, closed
Celcuity Inc
Phase 3
701
Bayreuth, Berlin, Dorf Mecklenburg, Lübeck, Mainz, Münster, Saarbrücken, Wuppertal
2022-12-08
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Bayreuth, Cologne, Dresden, Düsseldorf, Erlangen, Hanover, Leipzig, Worms
2022-08-31
Active, closed
Biogen
Phase 2
416
Mannheim, Tübingen, Ulm, Bayreuth, München, Erbach im Odenwald, Göttingen, Bonn
2022-08-24
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Böblingen, Bayreuth, Homburg
2022-08-23
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Tübingen, Ulm, Bayreuth, Munich, Westerstede, Düsseldorf, Chemnitz, Leipzig
2022-05-03
Recruiting
Dominik Paul Modest
Phase 3
507
Amberg, Bad Saarow, Bayreuth, Berlin, Bochum, Bonn, Bremen, Chemnitz
2021-12-06
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Amberg, Bayreuth, Berlin, Cologne, Düsseldorf, Erfurt, Frankfurt, Halle
2021-08-25
Active, closed
Biotronik AG
Observational
160
Bayreuth, Essen, Flensburg, Jena, Münster, Tübingen
2021-08-10
Active, closed
Pfizer
Observational
1,407
Bayreuth, Nuremberg, Cottbus, Goslar, Bonn, Bad Mergentheim, Berlin, Bremen
2020-10-27
Recruiting
Takeda
Phase 2
210
Bayreuth, Berlin, Bonn, Düsseldorf, Esslingen am Neckar, Halle, Leipzig, Mainz
2020-08-19
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
5,000
Aschaffenburg, Bad Aibling, Bad Neustadt an der Saale, Bayreuth, Coburg, Freyung, München, Neumarkt
2020-08-10
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Aachen, Bayreuth, Dresden, Mönchengladbach, München
2019-06-24
Active, closed
European LeukemiaNet
Phase 2
75
Freiburg im Breisgau, Mannheim, München, Hannover, Aachen, Bayreuth, Chemnitz, Esslingen am Neckar
2016-09
Active, closed
University Hospital Schleswig-Holstein
Not applicable
2,324
Amberg, Aue, Bad Saarow, Bayreuth, Berlin, Bocholt, Bremen, Buchholz
2015-06-16
Active, closed
Karolinska University Hospital
Phase 3
2,017
Aachen, Bamberg, Bayreuth, Berlin, Bietigheim, Bonn, Böblingen, Celle
2007-02
Rows per page Showing 1–34 of 34
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/bayreuth

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 34 of those studies with a site in Bayreuth.

How many clinical trials are recruiting in Bayreuth?

18 of the 34 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 16 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bayreuth), 34 studies
PhaseStudiesRecruitingShare
Phase 313638.2%
Observational8423.5%
Not applicable5314.7%
Phase 25314.7%
Phase 1215.9%
Phase 1/2112.9%

Most active sponsors

Lead sponsors with the most studies (Bayreuth)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche20
Karuna Therapeutics, Inc., a Bristol Myers Squibb company22
NovaGo Therapeutics AG21
Takeda22
Ad scientiam10
Angel Argiles10
AstraZeneca11
Biogen10
Biotronik AG10
Bristol-Myers Squibb10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.